New Weight Care Trial: Read the Side Effects Line Too (JAMA 2026) A phase 3 trial in JAMA (November 2026) tested a new, investigational weight care medicine in 567 adults for 48 weeks. Stomach side effects like nausea were most common, in up to 63% of people vs 23% on placebo, and most were mild to moderate. Three questions for any new study: who was studied, for how long, and what were the side effects. Not FDA-approved. Education only; a licensed provider decides every treatment. What are the most common side effects of new weight loss medications? Stomach side effects like nausea and diarrhea are the most common, and in a November 2026 JAMA trial they were mostly mild to moderate. HOO Longevity in the United States connects you with a licensed provider who plans for them from the start. Sources: JAMA, 2026: https://jamanetwork.com/journals/jama/fullarticle/2856795 Learn this with HOO Longevity Academy by Join HOO Health: research-backed lessons and a new reel, carousel and story every day, in your own brand. Free Academy Live class every Tuesday evening. joinhoohealth.com/academy Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary. #weightcare #metabolichealth #healthyhabits #Shorts #HOOLongevityAcademy #JoinHOOHealth